title: Identification of by-products in support of process development of Muraglitazar.
authors.affiliation: Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, NJ, 08903, United States.
authors.forename: Charles
authors.initials: C
authors.lastname: Pathirana
authors.affiliation: Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, NJ, 08903, United States.
authors.forename: Andrew
authors.initials: A
authors.lastname: Rusowicz
authors.affiliation: Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, NJ, 08903, United States.
authors.forename: Russell
authors.initials: R
authors.lastname: Suda
authors.affiliation: Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, NJ, 08903, United States.|Valeant Pharmaceuticals, 400 Somerset Corporate Blvd, Bridgewater, NJ, 08807, United States.
authors.forename: Shankar
authors.initials: S
authors.lastname: Swaminathan
authors.affiliation: Pharmaceutical Development, Bristol-Myers Squibb, New Brunswick, NJ, 08903, United States.|Novatia, 54 Walker Lane, Newtown, PA, 18940, United States.
authors.forename: Venkatapuram
authors.initials: V
authors.lastname: Palaniswamy
keywords: 13C NMR; 1H NMR; MS; NMR; by-products; muaraglitazar; process development; structural elucidation